Target Details
| UniProt AC | P04049 |
|---|---|
| Gene Symbol | RAF1 |
| Protein Name | RAF proto-oncogene serine/threonine-protein kinase |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00130 (C1_1) PF07714 (PK_Tyr_Ser-Thr) PF02196 (RBD) |
Summary
- Multi-target molecules 2,133
- Clinical molecules 20
- Avg pChEMBL 8.1
KEGG Pathways (84)
- Acute myeloid leukemia
- Alcoholism
- Alzheimer disease
- Apelin signaling pathway
- Apoptosis
- Autophagy - animal
- Axon guidance
- B cell receptor signaling pathway
- Bladder cancer
- Breast cancer
- C-type lectin receptor signaling pathway
- Cadherin signaling
- Cellular senescence
- Central carbon metabolism in cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Chronic myeloid leukemia
- Colorectal cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Fc gamma R-mediated phagocytosis
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH secretion
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- Influenza A
- Insulin signaling pathway
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanogenesis
- Melanoma
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Neutrophil extracellular trap formation
- Non-small cell lung cancer
- Oxytocin signaling pathway
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phospholipase D signaling pathway
- Progesterone-mediated oocyte maturation
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Renal cell carcinoma
- Salmonella infection
- Serotonergic synapse
- Signaling pathways regulating pluripotency of stem cells
- Sphingolipid signaling pathway
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Tuberculosis
- VEGF signaling pathway
- Vascular smooth muscle contraction
- cAMP signaling pathway
- cGMP-PKG signaling pathway
- mTOR signaling pathway
Associated Diseases (4)
Active Molecules (2,133)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
ZNHFSALJUQMPRP
|
7.8 | IC50 | 2 | — | |
IBCHCVVUXNIOQD
|
7.8 | IC50 | 2 | — | |
DHMFGGZSCPEWEE
|
7.8 | IC50 | 2 | — | |
GNDBDDNLWIOKDN
|
7.8 | IC50 | 5 | — | |
KNOQVYGPDZKJHQ
|
7.8 | IC50 | 2 | — | |
MCKKYADDOIQSEO
|
7.8 | IC50 | 2 | — | |
NPTOBOLZVNSDPN
|
7.8 | IC50 | 2 | — | |
QCANTRHJQVRPBP
|
7.8 | IC50 | 2 | — | |
MTBBLOULWCEKIP
|
7.8 | IC50 | 2 | — | |
DTTIYMKMNDLWNE
|
7.8 | IC50 | 2 | — | |
SRJGYTJLHCQTJK
|
7.8 | IC50 | 2 | — | |
XRTVFJCRUVMBFK
|
7.8 | IC50 | 2 | — | |
AQMWNANHLXNIPM
|
7.8 | IC50 | 2 | — | |
QJAWUBFLIUVCAW
|
7.8 | IC50 | 2 | — | |
UVHWVZCBNZYLKV
|
7.8 | IC50 | 2 | — | |
ZDWXGFSUCOUHQJ
|
7.8 | IC50 | 2 | — | |
ZWDFTCLGYJOUCA
|
7.8 | IC50 | 2 | — | |
ACFUSXUXHYFMOC
|
7.8 | IC50 | 2 | — | |
CZUGFURKAUPQAE
|
7.8 | IC50 | 3 | — | |
JVSMBUXACUSJML
|
7.8 | IC50 | 2 | — | |
VHUWQAHBOVJNLS
|
7.8 | IC50 | 2 | — | |
XGWAWSZKPLTUCQ
|
7.8 | IC50 | 2 | — | |
ZJDFSKSBQBPOSK
|
7.8 | IC50 | 24 | Yes | |
MLISSYIWIFCVRT
|
7.7 | IC50 | 3 | — | |
OCRUKNPFPIICEW
|
7.7 | IC50 | 2 | — | |
PHWHELVHLQDYNV
|
7.7 | IC50 | 2 | — | |
DULDWOWMSFBGBX
|
7.7 | IC50 | 2 | — | |
BNXCJALWTRAHMA
|
7.7 | IC50 | 2 | — | |
KTRKLZSMHABDCC
|
7.7 | IC50 | 2 | — | |
KTRKLZSMHABDCC
|
7.7 | IC50 | 2 | — | |
LQSGDXCDNZWTJN
|
7.7 | IC50 | 17 | — | |
MBCDKSSXEBSIEN
|
7.7 | IC50 | 2 | — | |
MSLRCTIJTGCYGK
|
7.7 | IC50 | 3 | — | |
PMAGHRSQJVNSPS
|
7.7 | IC50 | 2 | — | |
UZPXHYLFKLVCPZ
|
7.7 | IC50 | 3 | — | |
FUYFCWCWWSYMIR
|
7.7 | IC50 | 2 | — | |
ACGNJFZSGIKELN
|
7.7 | IC50 | 3 | — | |
HAWJEUPJDSDRMP
|
7.7 | IC50 | 2 | — | |
LZVVSWVIESQYLD
|
7.7 | IC50 | 2 | — | |
SGXJRYMLWWEIRD
|
7.7 | IC50 | 2 | — | |
VIHOLRDHXHCYBI
|
7.7 | IC50 | 2 | — | |
YKUDVEVHRUJXLV
|
7.7 | IC50 | 5 | — | |
AOPQJMHJLHBQIX
|
7.7 | IC50 | 2 | — | |
RASLNBWNIHACCU
|
7.7 | IC50 | 2 | — | |
CBEGWCPFZLRDSX
|
7.7 | IC50 | 2 | — | |
CBEGWCPFZLRDSX
|
7.7 | IC50 | 2 | — | |
FXNBBQANCQCLGY
|
7.7 | IC50 | 2 | — | |
HHNZAJOXHSVYML
|
7.7 | IC50 | 2 | — | |
LKMCVOPCAQBIKI
|
7.7 | IC50 | 3 | — | |
RFSFIDGEFVXSQM
|
7.7 | IC50 | 12 | Yes |